SlideShare uma empresa Scribd logo
1 de 45
Baixar para ler offline
Tracking Medicine ,[object Object],[object Object],[object Object]
 
Understanding Variations in the Way Medicine is Practiced ,[object Object],[object Object],[object Object]
 
Vermont Map from “Science” From  “Science,”   December 14, 1973. New Hampshire Massachusetts New York Quebec
Morrisville and Waterbury Center
 
 
Tonsillectomy Rate per 10,000 Children Among 13 Vermont Hospital Service Areas 0 50 100 150 200 250 300 350 400 450 Morrisville 1969
Stages of Facing Reality ,[object Object],[object Object],[object Object],[object Object]
Tonsillectomy Rate per 10,000 Children Among 13 Vermont Hospital Service Areas 0 50 100 150 200 250 300 350 400 450 Morrisville Morrisville 1969 1973
1.5-2 x 2-3 x 1.5-2 x 2-3 x
Table 2.1. A Test of Consumer Contribution to Small Area Variations in Health Care Delivery: Randolph and Middlebury, VT (continued) ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Science,  14 December, 1973 ,[object Object],[object Object]
Understanding Variations in the Way Medicine is Practiced ,[object Object],[object Object]
 
 
Which rate is right?  Impact of improved decision quality on surgery rates: BPH Knowledge of relevant treatment options and  outcomes Concordance between patient values and care received
Learning what works and what patients want ,[object Object],[object Object],[object Object]
The Dartmouth Atlas Project:  306 hospital referral regions Ongoing Study of Traditional Medicare Population USA
Unwarranted Variation in Health Care Delivery: ,[object Object],[object Object]
The Three Categories of Unwarranted Variation in Health Care Delivery ,[object Object],[object Object],[object Object],[object Object]
Preference-Sensitive Care  ,[object Object],[object Object],[object Object]
Conditions involving preference-sensitive surgical decisions ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Knee Replacement: An Example of Preference-Sensitive Care Ratio of knee replacement rates to the U.S. average (2005 ) 1 .30 to  1 .75 (46) 1 .10 to <  1 .30 (78) 0 .90 to <  1 .10 (106) 0 .75 to <  0 .90 (53) 0 .41 to <  0 .75 (23) Not Populated
Total Knee replacement for Arthritis per 1,000 Medicare enrollees among 306 Hospital Referral Regions Red dot = U.S. average: 4.03 5.64  40% increase 1.0 3.0 5.0 7.0 9.0 11.0 1992-93 2000-01
Relationship Between Knee Replacement Rates Among Hospital Referral Regions in 1992-93 and 2000-01 0.0 2.0 4.0 6.0 8.0 10.0 12.0 0.0 2.0 4.0 6.0 8.0 10.0 12.0 Knee Replacement (1992-93) Knee Replacement (2000-01) R 2  = 0.75
 
Determining the Need for Hip and Knee Arthroplasty:  The Role of Clinical Severity and Patients’ Preferences  ,[object Object]
Seattle 4.7 Tacoma 5.9 Spokane 6.9 Everett 4.0 Wenatchee 7.9
Wenatchee 9.2 Spokane 9.1 Tacoma 8.3 Seattle 6.8 Everett 6.5
Wenatchee 9.9 Seattle 2.4 Tacoma 4.0 Spokane 6.0 Bellevue   1.7
Spokane 4.3 Tacoma 3.5 Seattle 2.5 Renton 2.2
Tacoma 8.9 Spokane 8.9 Seattle 6.4 Port Angels 5.0 Bellingham 14.9
Bellingham 19.0 Spokane 13.2 Tacoma 12.3 Seattle 8.9 Port Angels 8.2
Bottom Line Implication:    Clinical Appropriateness should be based on sound evaluation of treatment options (outcomes research) To Avoid Wrong Patient Surgery, Medical Necessity should be based on Informed Patient Choice among Clinically Appropriate Options
Supply-Sensitive Care  ,[object Object],[object Object],[object Object]
Association between hospital beds per 1,000 and discharges per 1,000 among Medicare Enrollees: 306 Hospital Regions Hip Fracture R 2  = 0.06 All Medical Conditions R 2  = 0.54 0 50 100 150 200 250 300 350 400 1.0 2.0 3.0 4.0 5.0 6.0 Acute Care Beds Discharge Rate
Association between cardiologists and visits per person to cardiologists among Medicare enrollees: 306 Regions   R 2 = 0.49 Number of Visits to Cardiologists 0.0 0.5 1.0 1.5 2.0 2.5 0.0 2.5 5.0 7.5 10.0 12.5 15.0 Number of Cardiologists per 100,000
 
 
Contrasting Practice Patterns in Managing Chronic Illness During Last Two Years of Life (Deaths 2001-2005)    Regions in Highest and Lowest HCI Index Quintiles  Source: Dartmouth Atlas Database Resource input Lowest Quintile Highest  Quintile Ratio H/L Medicare $ per capita $38,300 $60,800 1.59 Physician Labor/1,000 All Physicians  16.6 29.5 1.78 Medical Specialists 5.6 13.1 2.35 Primary Care Doctors 7.4 11.5 1.55
Contrasting Practice Patterns in Managing Chronic Illness in Regions (HRRs) Ranked in Highest and Lowest Utilization Quintile (patients in their last 2 years of life) Low HRRs High HRRs Ratio H/L End of Life Care Hospital Days (L6M) 8.5 15.6 1.83 Hospital MD Visit (L6M) 12.9 36.3 2.82 % Seeing 10 or more MDs 20.8 43.7 2.16 % Deaths in ICUs  14.3 23.2 1.63
End of life care for Chronic Illness at selected  academic medical centers (deaths 2001-05) Hospital Name NYU Medical Center UCLA Medical Center Brigham and Women's Johns Hopkins Tufts-New England Beth Israel Deaconess Boston Medical Center Massachusetts General Cleveland Clinic Mayo Clinic (St. Mary's) University of Wisconsin Total Medicare spending 105,068 93,842 87,721 85,729 85,387 83,345 79,672 78,666 55,333 53,432 49,477 % of deaths with ICU admission 35.1 37.9 26.2 23.2 28.5 23.5 28.6 22.5 23.1 21.8 16.1
Thank You!!!!! Dartmouthatlas.org

Mais conteúdo relacionado

Mais procurados

Health Insurance and Inter Hospital Transfer of Patients with Acute Myocardia...
Health Insurance and Inter Hospital Transfer of Patients with Acute Myocardia...Health Insurance and Inter Hospital Transfer of Patients with Acute Myocardia...
Health Insurance and Inter Hospital Transfer of Patients with Acute Myocardia...Leonard Davis Institute of Health Economics
 
Central Adiposity and Mortality after First-Ever Acute Ischemic Stroke
Central Adiposity and Mortality after First-Ever Acute Ischemic StrokeCentral Adiposity and Mortality after First-Ever Acute Ischemic Stroke
Central Adiposity and Mortality after First-Ever Acute Ischemic StrokeErwin Chiquete, MD, PhD
 
Sackett bmj 1994 what measures of efficacy should journal articles provide bu...
Sackett bmj 1994 what measures of efficacy should journal articles provide bu...Sackett bmj 1994 what measures of efficacy should journal articles provide bu...
Sackett bmj 1994 what measures of efficacy should journal articles provide bu...Alejandro Mateo
 
Shannon Brownlee - SIIPC 2014
Shannon Brownlee - SIIPC 2014Shannon Brownlee - SIIPC 2014
Shannon Brownlee - SIIPC 2014SIIPC2014
 
Cost burdenofchronic pain
Cost burdenofchronic painCost burdenofchronic pain
Cost burdenofchronic painPaul Coelho, MD
 
Health System and Beneficiary Costs Associated With Intensive End-of-Life Med...
Health System and Beneficiary Costs Associated With Intensive End-of-Life Med...Health System and Beneficiary Costs Associated With Intensive End-of-Life Med...
Health System and Beneficiary Costs Associated With Intensive End-of-Life Med...Δρ. Γιώργος K. Κασάπης
 
Journal club pancreaticoduodenctomy
Journal club pancreaticoduodenctomy Journal club pancreaticoduodenctomy
Journal club pancreaticoduodenctomy Sujan Shrestha
 
Blood transfusions 2016
Blood transfusions 2016Blood transfusions 2016
Blood transfusions 2016Vanessa Cruz
 
Clinical oncology-can-observational-research-impact-clinical-decision-making
Clinical oncology-can-observational-research-impact-clinical-decision-makingClinical oncology-can-observational-research-impact-clinical-decision-making
Clinical oncology-can-observational-research-impact-clinical-decision-makingsmithjgrace
 
BSCThesis_11324066
BSCThesis_11324066BSCThesis_11324066
BSCThesis_11324066Marie Murphy
 

Mais procurados (16)

Annotation Editorial
Annotation EditorialAnnotation Editorial
Annotation Editorial
 
Health Insurance and Inter Hospital Transfer of Patients with Acute Myocardia...
Health Insurance and Inter Hospital Transfer of Patients with Acute Myocardia...Health Insurance and Inter Hospital Transfer of Patients with Acute Myocardia...
Health Insurance and Inter Hospital Transfer of Patients with Acute Myocardia...
 
Central Adiposity and Mortality after First-Ever Acute Ischemic Stroke
Central Adiposity and Mortality after First-Ever Acute Ischemic StrokeCentral Adiposity and Mortality after First-Ever Acute Ischemic Stroke
Central Adiposity and Mortality after First-Ever Acute Ischemic Stroke
 
5.14.11.public health
5.14.11.public health5.14.11.public health
5.14.11.public health
 
Geriatric oncology
Geriatric oncologyGeriatric oncology
Geriatric oncology
 
Cga
CgaCga
Cga
 
Sackett bmj 1994 what measures of efficacy should journal articles provide bu...
Sackett bmj 1994 what measures of efficacy should journal articles provide bu...Sackett bmj 1994 what measures of efficacy should journal articles provide bu...
Sackett bmj 1994 what measures of efficacy should journal articles provide bu...
 
Shannon Brownlee - SIIPC 2014
Shannon Brownlee - SIIPC 2014Shannon Brownlee - SIIPC 2014
Shannon Brownlee - SIIPC 2014
 
Ata2015
Ata2015Ata2015
Ata2015
 
Cost burdenofchronic pain
Cost burdenofchronic painCost burdenofchronic pain
Cost burdenofchronic pain
 
Medicares Coverage with Evidence Development Policy 4.21.10
Medicares Coverage with Evidence Development Policy 4.21.10Medicares Coverage with Evidence Development Policy 4.21.10
Medicares Coverage with Evidence Development Policy 4.21.10
 
Health System and Beneficiary Costs Associated With Intensive End-of-Life Med...
Health System and Beneficiary Costs Associated With Intensive End-of-Life Med...Health System and Beneficiary Costs Associated With Intensive End-of-Life Med...
Health System and Beneficiary Costs Associated With Intensive End-of-Life Med...
 
Journal club pancreaticoduodenctomy
Journal club pancreaticoduodenctomy Journal club pancreaticoduodenctomy
Journal club pancreaticoduodenctomy
 
Blood transfusions 2016
Blood transfusions 2016Blood transfusions 2016
Blood transfusions 2016
 
Clinical oncology-can-observational-research-impact-clinical-decision-making
Clinical oncology-can-observational-research-impact-clinical-decision-makingClinical oncology-can-observational-research-impact-clinical-decision-making
Clinical oncology-can-observational-research-impact-clinical-decision-making
 
BSCThesis_11324066
BSCThesis_11324066BSCThesis_11324066
BSCThesis_11324066
 

Semelhante a Wennberg at Group Health 3-25-11

From Overtreatment to Patient-Centered Care
From Overtreatment to  Patient-Centered CareFrom Overtreatment to  Patient-Centered Care
From Overtreatment to Patient-Centered CareNASHP HealthPolicy
 
FCCC Multi-Year Study Poster Presentation
FCCC Multi-Year Study Poster PresentationFCCC Multi-Year Study Poster Presentation
FCCC Multi-Year Study Poster PresentationKesha Stone, MPH
 
Evidence TableEvidence TablePICOT Question[Insert here]APA Sourc
Evidence TableEvidence TablePICOT Question[Insert here]APA SourcEvidence TableEvidence TablePICOT Question[Insert here]APA Sourc
Evidence TableEvidence TablePICOT Question[Insert here]APA SourcBetseyCalderon89
 
MBQIP 2011 Missouri
MBQIP 2011 Missouri MBQIP 2011 Missouri
MBQIP 2011 Missouri learfield
 
Gianfranco Domenighetti | Evidence of medical misuse in Switzerland | 2013 Thun
Gianfranco Domenighetti | Evidence of medical misuse in Switzerland | 2013 ThunGianfranco Domenighetti | Evidence of medical misuse in Switzerland | 2013 Thun
Gianfranco Domenighetti | Evidence of medical misuse in Switzerland | 2013 ThunAngela Greco
 
APDS Lecture 2005-10-18
APDS Lecture 2005-10-18APDS Lecture 2005-10-18
APDS Lecture 2005-10-18largess
 
CHD Secondary Prevention Clinics in Primary Care; a critical assessment
CHD Secondary Prevention Clinics in Primary Care; a critical assessmentCHD Secondary Prevention Clinics in Primary Care; a critical assessment
CHD Secondary Prevention Clinics in Primary Care; a critical assessmentJosep Vidal-Alaball
 
Science and Policy Making in Public Health
Science and Policy Making in Public HealthScience and Policy Making in Public Health
Science and Policy Making in Public HealthAlbert Farrugia
 
Integrative oncology traci pantuso jennie crews may2016 pci conference
Integrative oncology traci pantuso jennie crews may2016 pci conferenceIntegrative oncology traci pantuso jennie crews may2016 pci conference
Integrative oncology traci pantuso jennie crews may2016 pci conferencewwuextendeded
 
Balance etween quality and cost
Balance etween  quality and costBalance etween  quality and cost
Balance etween quality and costsummer elmorshidy
 
Pathophysiology Of Heart Failure
Pathophysiology Of Heart FailurePathophysiology Of Heart Failure
Pathophysiology Of Heart FailureStephanie King
 
Denise Lee Publication
Denise Lee PublicationDenise Lee Publication
Denise Lee PublicationDenise Lee
 

Semelhante a Wennberg at Group Health 3-25-11 (20)

From Overtreatment to Patient-Centered Care
From Overtreatment to  Patient-Centered CareFrom Overtreatment to  Patient-Centered Care
From Overtreatment to Patient-Centered Care
 
Keynote Address: Jack Wennberg
Keynote Address: Jack WennbergKeynote Address: Jack Wennberg
Keynote Address: Jack Wennberg
 
5.14.11.public health
5.14.11.public health5.14.11.public health
5.14.11.public health
 
5.14.11.public health
5.14.11.public health5.14.11.public health
5.14.11.public health
 
5.14.11.public health
5.14.11.public health5.14.11.public health
5.14.11.public health
 
FCCC Multi-Year Study Poster Presentation
FCCC Multi-Year Study Poster PresentationFCCC Multi-Year Study Poster Presentation
FCCC Multi-Year Study Poster Presentation
 
Evidence TableEvidence TablePICOT Question[Insert here]APA Sourc
Evidence TableEvidence TablePICOT Question[Insert here]APA SourcEvidence TableEvidence TablePICOT Question[Insert here]APA Sourc
Evidence TableEvidence TablePICOT Question[Insert here]APA Sourc
 
How to Improve the Quality of Medical Decisions
How to Improve the Quality of Medical DecisionsHow to Improve the Quality of Medical Decisions
How to Improve the Quality of Medical Decisions
 
MBQIP 2011 Missouri
MBQIP 2011 Missouri MBQIP 2011 Missouri
MBQIP 2011 Missouri
 
Gianfranco Domenighetti | Evidence of medical misuse in Switzerland | 2013 Thun
Gianfranco Domenighetti | Evidence of medical misuse in Switzerland | 2013 ThunGianfranco Domenighetti | Evidence of medical misuse in Switzerland | 2013 Thun
Gianfranco Domenighetti | Evidence of medical misuse in Switzerland | 2013 Thun
 
APDS Lecture 2005-10-18
APDS Lecture 2005-10-18APDS Lecture 2005-10-18
APDS Lecture 2005-10-18
 
CHD Secondary Prevention Clinics in Primary Care; a critical assessment
CHD Secondary Prevention Clinics in Primary Care; a critical assessmentCHD Secondary Prevention Clinics in Primary Care; a critical assessment
CHD Secondary Prevention Clinics in Primary Care; a critical assessment
 
Hospital Racial Composition and Differences 4.4.08
Hospital Racial Composition and Differences 4.4.08Hospital Racial Composition and Differences 4.4.08
Hospital Racial Composition and Differences 4.4.08
 
Science and Policy Making in Public Health
Science and Policy Making in Public HealthScience and Policy Making in Public Health
Science and Policy Making in Public Health
 
Integrative oncology traci pantuso jennie crews may2016 pci conference
Integrative oncology traci pantuso jennie crews may2016 pci conferenceIntegrative oncology traci pantuso jennie crews may2016 pci conference
Integrative oncology traci pantuso jennie crews may2016 pci conference
 
Balance etween quality and cost
Balance etween  quality and costBalance etween  quality and cost
Balance etween quality and cost
 
Pathophysiology Of Heart Failure
Pathophysiology Of Heart FailurePathophysiology Of Heart Failure
Pathophysiology Of Heart Failure
 
Race and Variations in Operative Treatment 10.22.09
Race and Variations in Operative Treatment 10.22.09Race and Variations in Operative Treatment 10.22.09
Race and Variations in Operative Treatment 10.22.09
 
Denise Lee Publication
Denise Lee PublicationDenise Lee Publication
Denise Lee Publication
 
American Journal of Anesthesia & Clinical Research
American Journal of Anesthesia & Clinical ResearchAmerican Journal of Anesthesia & Clinical Research
American Journal of Anesthesia & Clinical Research
 

Mais de Group Health Cooperative

Prevention of Type 2 Diabetes and Stemming the Tide
Prevention of Type 2 Diabetes and Stemming the TidePrevention of Type 2 Diabetes and Stemming the Tide
Prevention of Type 2 Diabetes and Stemming the TideGroup Health Cooperative
 
Best Practices for Managing High-Risk Clinical Populations
Best Practices for Managing High-Risk Clinical PopulationsBest Practices for Managing High-Risk Clinical Populations
Best Practices for Managing High-Risk Clinical PopulationsGroup Health Cooperative
 
Using the Electronic Medical Record to Drive Improved Patient Outcomes
Using the Electronic Medical Record to Drive Improved Patient Outcomes Using the Electronic Medical Record to Drive Improved Patient Outcomes
Using the Electronic Medical Record to Drive Improved Patient Outcomes Group Health Cooperative
 
The Opioid Analgesic Epidemic: How it Happened
The Opioid Analgesic Epidemic:  How it HappenedThe Opioid Analgesic Epidemic:  How it Happened
The Opioid Analgesic Epidemic: How it HappenedGroup Health Cooperative
 
Barriers to opioid monitoring in primary care
Barriers to opioid monitoring in primary careBarriers to opioid monitoring in primary care
Barriers to opioid monitoring in primary careGroup Health Cooperative
 
Implementing chronic opioid therapy guidelines at Group Health Cooperative
Implementing chronic opioid therapy guidelines at Group Health CooperativeImplementing chronic opioid therapy guidelines at Group Health Cooperative
Implementing chronic opioid therapy guidelines at Group Health CooperativeGroup Health Cooperative
 
Principles for more cautious and selective opioid prescribing for chronic non...
Principles for more cautious and selective opioid prescribing for chronic non...Principles for more cautious and selective opioid prescribing for chronic non...
Principles for more cautious and selective opioid prescribing for chronic non...Group Health Cooperative
 
State of the evidence on chronic opioid therapy and risk mitigation
State of the evidence on chronic opioid therapy and risk mitigation State of the evidence on chronic opioid therapy and risk mitigation
State of the evidence on chronic opioid therapy and risk mitigation Group Health Cooperative
 
The Medical Home Model: Patient Centered Care
The Medical Home Model: Patient Centered CareThe Medical Home Model: Patient Centered Care
The Medical Home Model: Patient Centered CareGroup Health Cooperative
 
Emergency Department/Hospital Inpatient Initiative
Emergency Department/Hospital Inpatient InitiativeEmergency Department/Hospital Inpatient Initiative
Emergency Department/Hospital Inpatient InitiativeGroup Health Cooperative
 

Mais de Group Health Cooperative (19)

Prevention of Type 2 Diabetes and Stemming the Tide
Prevention of Type 2 Diabetes and Stemming the TidePrevention of Type 2 Diabetes and Stemming the Tide
Prevention of Type 2 Diabetes and Stemming the Tide
 
Best Practices for Managing High-Risk Clinical Populations
Best Practices for Managing High-Risk Clinical PopulationsBest Practices for Managing High-Risk Clinical Populations
Best Practices for Managing High-Risk Clinical Populations
 
Using the Electronic Medical Record to Drive Improved Patient Outcomes
Using the Electronic Medical Record to Drive Improved Patient Outcomes Using the Electronic Medical Record to Drive Improved Patient Outcomes
Using the Electronic Medical Record to Drive Improved Patient Outcomes
 
Becoming a Learning Healthcare System
Becoming a Learning Healthcare SystemBecoming a Learning Healthcare System
Becoming a Learning Healthcare System
 
Learning Health Care Systems
Learning Health Care SystemsLearning Health Care Systems
Learning Health Care Systems
 
Opioids: A Public Health Emergency
Opioids: A Public Health EmergencyOpioids: A Public Health Emergency
Opioids: A Public Health Emergency
 
The Opioid Analgesic Epidemic: How it Happened
The Opioid Analgesic Epidemic:  How it HappenedThe Opioid Analgesic Epidemic:  How it Happened
The Opioid Analgesic Epidemic: How it Happened
 
Barriers to opioid monitoring in primary care
Barriers to opioid monitoring in primary careBarriers to opioid monitoring in primary care
Barriers to opioid monitoring in primary care
 
Implementing chronic opioid therapy guidelines at Group Health Cooperative
Implementing chronic opioid therapy guidelines at Group Health CooperativeImplementing chronic opioid therapy guidelines at Group Health Cooperative
Implementing chronic opioid therapy guidelines at Group Health Cooperative
 
Principles for more cautious and selective opioid prescribing for chronic non...
Principles for more cautious and selective opioid prescribing for chronic non...Principles for more cautious and selective opioid prescribing for chronic non...
Principles for more cautious and selective opioid prescribing for chronic non...
 
State of the evidence on chronic opioid therapy and risk mitigation
State of the evidence on chronic opioid therapy and risk mitigation State of the evidence on chronic opioid therapy and risk mitigation
State of the evidence on chronic opioid therapy and risk mitigation
 
National Summit On Opioid Safety
National Summit On Opioid  SafetyNational Summit On Opioid  Safety
National Summit On Opioid Safety
 
Chronic Opioid Therapy
Chronic Opioid TherapyChronic Opioid Therapy
Chronic Opioid Therapy
 
Shared Decision Making
Shared Decision MakingShared Decision Making
Shared Decision Making
 
The Medical Home Model: Patient Centered Care
The Medical Home Model: Patient Centered CareThe Medical Home Model: Patient Centered Care
The Medical Home Model: Patient Centered Care
 
Improving the Value of High-End Imaging
Improving the Value of High-End ImagingImproving the Value of High-End Imaging
Improving the Value of High-End Imaging
 
Shared Decision Making
Shared Decision MakingShared Decision Making
Shared Decision Making
 
Emergency Department/Hospital Inpatient Initiative
Emergency Department/Hospital Inpatient InitiativeEmergency Department/Hospital Inpatient Initiative
Emergency Department/Hospital Inpatient Initiative
 
Medical Home Model: Patient Centered Care
Medical Home Model: Patient Centered CareMedical Home Model: Patient Centered Care
Medical Home Model: Patient Centered Care
 

Último

ANEMIA IN PREGNANCY by Dr. Akebom Kidanemariam
ANEMIA IN PREGNANCY by Dr. Akebom KidanemariamANEMIA IN PREGNANCY by Dr. Akebom Kidanemariam
ANEMIA IN PREGNANCY by Dr. Akebom KidanemariamAkebom Gebremichael
 
Screening for colorectal cancer AAU.pptx
Screening for colorectal cancer AAU.pptxScreening for colorectal cancer AAU.pptx
Screening for colorectal cancer AAU.pptxtadehabte
 
Presentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPresentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPrerana Jadhav
 
Phytochemical Investigation of Drugs PDF.pdf
Phytochemical Investigation of Drugs PDF.pdfPhytochemical Investigation of Drugs PDF.pdf
Phytochemical Investigation of Drugs PDF.pdfDivya Kanojiya
 
Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Mohamed Rizk Khodair
 
Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!ibtesaam huma
 
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...sdateam0
 
Myelin Oligodendrocyte Glycoprotein antibody associated disease (MOGAD)
Myelin Oligodendrocyte Glycoprotein antibody associated disease (MOGAD)Myelin Oligodendrocyte Glycoprotein antibody associated disease (MOGAD)
Myelin Oligodendrocyte Glycoprotein antibody associated disease (MOGAD)MohamadAlhes
 
Chronic-Fatigue-Syndrome-CFS-Understanding-a-Complex-Disorder.pptx
Chronic-Fatigue-Syndrome-CFS-Understanding-a-Complex-Disorder.pptxChronic-Fatigue-Syndrome-CFS-Understanding-a-Complex-Disorder.pptx
Chronic-Fatigue-Syndrome-CFS-Understanding-a-Complex-Disorder.pptxSasikiranMarri
 
Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Prerana Jadhav
 
Plant Fibres used as Surgical Dressings PDF.pdf
Plant Fibres used as Surgical Dressings PDF.pdfPlant Fibres used as Surgical Dressings PDF.pdf
Plant Fibres used as Surgical Dressings PDF.pdfDivya Kanojiya
 
HERBS AS HEALTH FOOD - Brief introduction and therapeutic applications of: N...
HERBS AS HEALTH FOOD - Brief introduction and therapeutic applications of:  N...HERBS AS HEALTH FOOD - Brief introduction and therapeutic applications of:  N...
HERBS AS HEALTH FOOD - Brief introduction and therapeutic applications of: N...Divya Kanojiya
 
Musculoskeletal disorders: Osteoarthritis,.pptx
Musculoskeletal disorders: Osteoarthritis,.pptxMusculoskeletal disorders: Osteoarthritis,.pptx
Musculoskeletal disorders: Osteoarthritis,.pptxraviapr7
 
Hypersensitivity and its classification .pptx
Hypersensitivity and its classification .pptxHypersensitivity and its classification .pptx
Hypersensitivity and its classification .pptxAkshay Shetty
 
The next social challenge to public health: the information environment.pptx
The next social challenge to public health:  the information environment.pptxThe next social challenge to public health:  the information environment.pptx
The next social challenge to public health: the information environment.pptxTina Purnat
 
Valproic Acid. (VPA). Antiseizure medication
Valproic Acid.  (VPA). Antiseizure medicationValproic Acid.  (VPA). Antiseizure medication
Valproic Acid. (VPA). Antiseizure medicationMohamadAlhes
 
Nutrition of OCD for my Nutritional Neuroscience Class
Nutrition of OCD for my Nutritional Neuroscience ClassNutrition of OCD for my Nutritional Neuroscience Class
Nutrition of OCD for my Nutritional Neuroscience Classmanuelazg2001
 
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand UniversityCEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand UniversityHarshChauhan475104
 
Rheumatoid arthritis - Musculoskeletal disorders.ppt
Rheumatoid arthritis - Musculoskeletal disorders.pptRheumatoid arthritis - Musculoskeletal disorders.ppt
Rheumatoid arthritis - Musculoskeletal disorders.pptraviapr7
 

Último (20)

ANEMIA IN PREGNANCY by Dr. Akebom Kidanemariam
ANEMIA IN PREGNANCY by Dr. Akebom KidanemariamANEMIA IN PREGNANCY by Dr. Akebom Kidanemariam
ANEMIA IN PREGNANCY by Dr. Akebom Kidanemariam
 
Screening for colorectal cancer AAU.pptx
Screening for colorectal cancer AAU.pptxScreening for colorectal cancer AAU.pptx
Screening for colorectal cancer AAU.pptx
 
Presentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPresentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous System
 
Phytochemical Investigation of Drugs PDF.pdf
Phytochemical Investigation of Drugs PDF.pdfPhytochemical Investigation of Drugs PDF.pdf
Phytochemical Investigation of Drugs PDF.pdf
 
Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)
 
Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!
 
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
 
Myelin Oligodendrocyte Glycoprotein antibody associated disease (MOGAD)
Myelin Oligodendrocyte Glycoprotein antibody associated disease (MOGAD)Myelin Oligodendrocyte Glycoprotein antibody associated disease (MOGAD)
Myelin Oligodendrocyte Glycoprotein antibody associated disease (MOGAD)
 
Chronic-Fatigue-Syndrome-CFS-Understanding-a-Complex-Disorder.pptx
Chronic-Fatigue-Syndrome-CFS-Understanding-a-Complex-Disorder.pptxChronic-Fatigue-Syndrome-CFS-Understanding-a-Complex-Disorder.pptx
Chronic-Fatigue-Syndrome-CFS-Understanding-a-Complex-Disorder.pptx
 
Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.
 
Plant Fibres used as Surgical Dressings PDF.pdf
Plant Fibres used as Surgical Dressings PDF.pdfPlant Fibres used as Surgical Dressings PDF.pdf
Plant Fibres used as Surgical Dressings PDF.pdf
 
HERBS AS HEALTH FOOD - Brief introduction and therapeutic applications of: N...
HERBS AS HEALTH FOOD - Brief introduction and therapeutic applications of:  N...HERBS AS HEALTH FOOD - Brief introduction and therapeutic applications of:  N...
HERBS AS HEALTH FOOD - Brief introduction and therapeutic applications of: N...
 
Musculoskeletal disorders: Osteoarthritis,.pptx
Musculoskeletal disorders: Osteoarthritis,.pptxMusculoskeletal disorders: Osteoarthritis,.pptx
Musculoskeletal disorders: Osteoarthritis,.pptx
 
JANGAMA VISHA .pptx-
JANGAMA VISHA .pptx-JANGAMA VISHA .pptx-
JANGAMA VISHA .pptx-
 
Hypersensitivity and its classification .pptx
Hypersensitivity and its classification .pptxHypersensitivity and its classification .pptx
Hypersensitivity and its classification .pptx
 
The next social challenge to public health: the information environment.pptx
The next social challenge to public health:  the information environment.pptxThe next social challenge to public health:  the information environment.pptx
The next social challenge to public health: the information environment.pptx
 
Valproic Acid. (VPA). Antiseizure medication
Valproic Acid.  (VPA). Antiseizure medicationValproic Acid.  (VPA). Antiseizure medication
Valproic Acid. (VPA). Antiseizure medication
 
Nutrition of OCD for my Nutritional Neuroscience Class
Nutrition of OCD for my Nutritional Neuroscience ClassNutrition of OCD for my Nutritional Neuroscience Class
Nutrition of OCD for my Nutritional Neuroscience Class
 
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand UniversityCEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
 
Rheumatoid arthritis - Musculoskeletal disorders.ppt
Rheumatoid arthritis - Musculoskeletal disorders.pptRheumatoid arthritis - Musculoskeletal disorders.ppt
Rheumatoid arthritis - Musculoskeletal disorders.ppt
 

Wennberg at Group Health 3-25-11

  • 1.
  • 2.  
  • 3.
  • 4.  
  • 5. Vermont Map from “Science” From “Science,” December 14, 1973. New Hampshire Massachusetts New York Quebec
  • 7.  
  • 8.  
  • 9. Tonsillectomy Rate per 10,000 Children Among 13 Vermont Hospital Service Areas 0 50 100 150 200 250 300 350 400 450 Morrisville 1969
  • 10.
  • 11. Tonsillectomy Rate per 10,000 Children Among 13 Vermont Hospital Service Areas 0 50 100 150 200 250 300 350 400 450 Morrisville Morrisville 1969 1973
  • 12. 1.5-2 x 2-3 x 1.5-2 x 2-3 x
  • 13.
  • 14.
  • 15.
  • 16.  
  • 17.  
  • 18. Which rate is right? Impact of improved decision quality on surgery rates: BPH Knowledge of relevant treatment options and outcomes Concordance between patient values and care received
  • 19.
  • 20. The Dartmouth Atlas Project: 306 hospital referral regions Ongoing Study of Traditional Medicare Population USA
  • 21.
  • 22.
  • 23.
  • 24.
  • 25. Knee Replacement: An Example of Preference-Sensitive Care Ratio of knee replacement rates to the U.S. average (2005 ) 1 .30 to 1 .75 (46) 1 .10 to < 1 .30 (78) 0 .90 to < 1 .10 (106) 0 .75 to < 0 .90 (53) 0 .41 to < 0 .75 (23) Not Populated
  • 26. Total Knee replacement for Arthritis per 1,000 Medicare enrollees among 306 Hospital Referral Regions Red dot = U.S. average: 4.03 5.64 40% increase 1.0 3.0 5.0 7.0 9.0 11.0 1992-93 2000-01
  • 27. Relationship Between Knee Replacement Rates Among Hospital Referral Regions in 1992-93 and 2000-01 0.0 2.0 4.0 6.0 8.0 10.0 12.0 0.0 2.0 4.0 6.0 8.0 10.0 12.0 Knee Replacement (1992-93) Knee Replacement (2000-01) R 2 = 0.75
  • 28.  
  • 29.
  • 30. Seattle 4.7 Tacoma 5.9 Spokane 6.9 Everett 4.0 Wenatchee 7.9
  • 31. Wenatchee 9.2 Spokane 9.1 Tacoma 8.3 Seattle 6.8 Everett 6.5
  • 32. Wenatchee 9.9 Seattle 2.4 Tacoma 4.0 Spokane 6.0 Bellevue 1.7
  • 33. Spokane 4.3 Tacoma 3.5 Seattle 2.5 Renton 2.2
  • 34. Tacoma 8.9 Spokane 8.9 Seattle 6.4 Port Angels 5.0 Bellingham 14.9
  • 35. Bellingham 19.0 Spokane 13.2 Tacoma 12.3 Seattle 8.9 Port Angels 8.2
  • 36. Bottom Line Implication: Clinical Appropriateness should be based on sound evaluation of treatment options (outcomes research) To Avoid Wrong Patient Surgery, Medical Necessity should be based on Informed Patient Choice among Clinically Appropriate Options
  • 37.
  • 38. Association between hospital beds per 1,000 and discharges per 1,000 among Medicare Enrollees: 306 Hospital Regions Hip Fracture R 2 = 0.06 All Medical Conditions R 2 = 0.54 0 50 100 150 200 250 300 350 400 1.0 2.0 3.0 4.0 5.0 6.0 Acute Care Beds Discharge Rate
  • 39. Association between cardiologists and visits per person to cardiologists among Medicare enrollees: 306 Regions R 2 = 0.49 Number of Visits to Cardiologists 0.0 0.5 1.0 1.5 2.0 2.5 0.0 2.5 5.0 7.5 10.0 12.5 15.0 Number of Cardiologists per 100,000
  • 40.  
  • 41.  
  • 42. Contrasting Practice Patterns in Managing Chronic Illness During Last Two Years of Life (Deaths 2001-2005) Regions in Highest and Lowest HCI Index Quintiles Source: Dartmouth Atlas Database Resource input Lowest Quintile Highest Quintile Ratio H/L Medicare $ per capita $38,300 $60,800 1.59 Physician Labor/1,000 All Physicians 16.6 29.5 1.78 Medical Specialists 5.6 13.1 2.35 Primary Care Doctors 7.4 11.5 1.55
  • 43. Contrasting Practice Patterns in Managing Chronic Illness in Regions (HRRs) Ranked in Highest and Lowest Utilization Quintile (patients in their last 2 years of life) Low HRRs High HRRs Ratio H/L End of Life Care Hospital Days (L6M) 8.5 15.6 1.83 Hospital MD Visit (L6M) 12.9 36.3 2.82 % Seeing 10 or more MDs 20.8 43.7 2.16 % Deaths in ICUs 14.3 23.2 1.63
  • 44. End of life care for Chronic Illness at selected academic medical centers (deaths 2001-05) Hospital Name NYU Medical Center UCLA Medical Center Brigham and Women's Johns Hopkins Tufts-New England Beth Israel Deaconess Boston Medical Center Massachusetts General Cleveland Clinic Mayo Clinic (St. Mary's) University of Wisconsin Total Medicare spending 105,068 93,842 87,721 85,729 85,387 83,345 79,672 78,666 55,333 53,432 49,477 % of deaths with ICU admission 35.1 37.9 26.2 23.2 28.5 23.5 28.6 22.5 23.1 21.8 16.1

Notas do Editor

  1. Under the normative assumption that the “right rate” for a given procedure should be based on the choices made by informed patients (free of undue influence by the practice style preferences of their physicians or other unwarranted influences), the systematic implementation of decision aids among patient populations would offer the opportunity to obtain valid benchmarks for the “true” demand for a given treatment option. Such an opportunity presented itself to our research group in the early 1990’s when a decision aid we had designed to help patients decide between watchful waiting and surgery for their enlarge prostate was introduced in the urologic clinics in 2 pre-paid group practices, Kaiser-Permanente in Denver and Group Health Cooperative in Seattle. After the implementation of shared decision making, the population based rates for prostatectomy fell 40% , providing a benchmark for demand under shared decision making. (Rates in the control group, Group Health Cooperative’s Tacoma site, did not change.) giving us a benchmark for demand under shared decision making. When we compared this benchmark to the rates among the 306 region (blue dots in the above figures), it was of interest that the shared benchmark was at the extreme low end of the national distribution, suggesting that the rates of surgery in most US regions exceeded the amount that informed patients want.
  2. The essence of practice variation studies is the comparison of rates of use of medical care among defined populations. Sometimes the “population at risk” is the resident population living in a region. For example, the incidence of Medicare hospitalizations for hip fracture is measured by counting the number of residents who were hospitalized in a given period of time (the numerator of the rate) and dividing by the number of Medicare enrollees living in the same region (the denominator). The rates for discretionary surgery in this lecture are calculated this way as are a few examples supply-sensitive care. Sometimes, the populations selected for comparison are those at the same stage in the course of illness or health care needs.. Most effective care quality measures are calculated this way. For example, the quality of care for diabetic patients measure used in this lecture is based on a numerator that is a count of all diabetic patients who received the needed eye examination at least once over a 2 year period and a denominator is a count of all diabetic patients living in the region. The measures of supply-sensitive care at the end of life are also based on the experience of specific subpopulation. In these cases, the numerator is the number of events experienced by patients during the last six months of their life; the denominator is the number of patients who died. In the lecture, practice variations were viewed two ways: (1) the traditional Atlas strategy which examines variation among Medicare residents living in 306 hospital referral regions across the United States. (2 A newer method which examines variation on a hospital-speciific basis among patients with chronic illness who receive most of their care from well known academic medical centers (selected because they appeared on US News and World Reports 2001 list for the “Best Hospitals” for geriatric care and for treating cancer, heart disease or respiratory disease.)
  3. 21 As the name implies, supply-sensitive services are related to the supply of the resource that provides the service. This figure shows the association between supply of staffed hospital beds per 1,000 residents and the hospitalization rate for medical (non-surgical) condition among Medicare enrollees. More than half of the variation in discharge rates is associated with bed capacity. By contrast, hospitalization for hip fracture--one of the few conditions for which the pattern of variation is determined by the incidence of illness--shows little correlation with resource supply. The denominator for the utilization rates is the Medicare population resident in the region; the denominator for beds per 1,000 is the entire population of the region. The behavioral basis of this association must rest in Roemer’s law--the long- held hypothesis that hospital beds, once built (and staffed), tend to be filled. In my experience, the impact of beds per capita on clinical decision making is subliminal in the sense that clinicians are unaware of differences in practice style associated with the context of bed capacity. I gained this impression from interviews with clinicians practicing in Boston and New Haven and who were not aware of the 60% differences in hospitalization rates for medical conditions, even though some had practiced in both communities.
  4. 23 This figure illustrates the relationship between the number of cardiologists per 100,000 and the number of visits per person to cardiologists among the 306 regions. About half of the variation is “explained” by supply. The behavioral basis of this association seems clear: The Medicare population comprise a large shared of the patient load for cardiologists. Appointments to see physicians characteristically are fully “booked”--very few hours in the work week go unfilled. Most office visits are for established patients and the interval between revisit is governed by the size of the physician’s panel of patients. On average, regions with twice as many cardiologists per 100,000 will have twice as many available office visit hours. In the absence of evidence-based guidelines on the appropriate interval between revisits, available capacity governs the frequency of revisit. The strength of the association between physician supply and physician visit rates among Medicare population depends on the specialty. The association between internists and visits to internists is similar to that of cardiologists (and, together, these 2 specialties account for N% of visits to primary care and medical specialists). However, for family practice physicians, the association is much weaker with only about X% of visits (R2 = .xx) I believe the likely explanation rests in the much small proportion of their total visits that family practice physicians dedicate to patients 65 years of age and older: XX% of family practice visits are for patients 65 years of age and older, compared to yy% for general internists. The denominator for physician supply is census count for the region; for Medicare visits it is the number of enrollees living in each region.
  5. 1